Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
01/17/1995 | CA2007463C Dispensing devices powered by hydrogel |
01/17/1995 | CA1334007C Photoprotection compositions comprising sorbohydroxamic acid |
01/17/1995 | CA1334001C Stable pharmaceutical composition containing esmolol |
01/17/1995 | CA1334000C Coated veterinary implant comprising melatonin |
01/17/1995 | CA1333999C Drug and method for increasing the microcirculatory flow-rate and volume in the capillaries to the skin |
01/17/1995 | CA1333997C Cholesterol-lowering combination compositions of guar gum and niacin |
01/17/1995 | CA1333996C Dhp delayed release preparation |
01/17/1995 | CA1333994C Flavoured film-coated tablet |
01/17/1995 | CA1333993C Drug carriers |
01/16/1995 | CA2128034A1 Drug formulations comprising coated, very sparingly water-soluble drugs for inhalational pharmaceutical forms, and process for their preparation |
01/12/1995 | WO1995001324A1 Salmeterol xinafoate with controlled particle size |
01/12/1995 | WO1995001321A1 Neomorphic ibuprofen and methods of using same |
01/12/1995 | WO1995001221A1 Method and apparatus for the formation of particles |
01/12/1995 | WO1995001203A2 Implantable membrane encapsulation apparatus |
01/12/1995 | WO1995001186A1 Drug system |
01/12/1995 | WO1995001185A1 Stabilized pharmaceutical peptide compositions |
01/12/1995 | WO1995001183A1 Compositions for nasal administration of desmopressin |
01/12/1995 | WO1995001167A2 Incorporating poly-n-vinyl amide in a transdermal system |
01/12/1995 | WO1995001166A1 Encapsulated medicine |
01/12/1995 | WO1995001165A1 Medical use of organic aerogels and biodegradable organic aerogels |
01/12/1995 | WO1995001164A1 Method for preparing liposomes |
01/12/1995 | WO1995001163A1 Novel pharmaceutical peptide preparations for general delivery |
01/12/1995 | WO1995001162A1 Pharmaceutical emulsions containing bioactive steroids |
01/12/1995 | WO1995001161A1 Pack for use in, and method of hormonal replacement therapy |
01/12/1995 | WO1995001160A1 Stable topical retinoid compositions |
01/12/1995 | WO1995001156A1 Breath protection microcapsules |
01/12/1995 | WO1995001154A1 Oral care compositions |
01/12/1995 | WO1995001138A1 Implantable system for cell growth control |
01/12/1995 | WO1994008552A3 Dry powder inhaler |
01/12/1995 | DE4422938A1 Soft gelatin capsules |
01/12/1995 | DE4323174A1 Pharmaceutical and/or cosmetic composition, and the use of a composition of this type |
01/12/1995 | DE4322057A1 Tablet with improved bioavailability containing dichloromethylenediphosphonic acid as active ingredient |
01/12/1995 | CA2166460A1 Neomorphic ibuprofen and methods of using same |
01/12/1995 | CA2166116A1 Method and apparatus for sealing implantable, membrane encapsulation devices |
01/12/1995 | CA2165789A1 Encapsulated medicine |
01/12/1995 | CA2163860A1 Method for preparing liposomes |
01/12/1995 | CA2143667A1 Pharmaceutical emulsions containing bioactive steroids |
01/11/1995 | EP0633058A1 Process for preparing spherules |
01/11/1995 | EP0633024A1 Topically administrable zinc phthalocyanine compositions |
01/11/1995 | EP0633020A1 Method of producing sustained-release preparation |
01/11/1995 | EP0633019A1 Pressurized gas packagings using polyoxyethylene glyceryl fatty acid esters as suspension stabilizers and valve lubricants |
01/11/1995 | EP0632723A1 Use of transglutaminase inhibitor for the treatment of scar tissue |
01/11/1995 | EP0632721A1 Sustained release composition and method utilizing xanthan gum and an active ingredient |
01/11/1995 | EP0632720A1 Alkyl-substituted cellulose-based sustained-release oral drug dosage forms |
01/11/1995 | EP0632692A1 Dispersible products. |
01/11/1995 | EP0563227B1 Cosmetic or pharmaceutical composition in the form of a rigid gel, particularly for containing inclusions therein |
01/11/1995 | EP0552227B1 Orally administered solvent-free pharmaceutical preparation with delayed active-substance release, and a method of preparing the preparation |
01/11/1995 | EP0538335B1 Dosage form for administering a drug to effect circadian therapy |
01/11/1995 | CN1097137A Lactation-promoting health-care oral liquor for lying-in woman |
01/11/1995 | CN1097136A Lactation-promoting nutrient oral liquor for lying-in woman |
01/10/1995 | US5380927 Process for preparing optically active 2-aryl-alkanoic acids, in particular 2-aryl-propionic acids |
01/10/1995 | US5380922 Benzenedimethanol suitable for micronisation |
01/10/1995 | US5380790 Process for the preparation of acrylic polymers for pharmaceutical coatings |
01/10/1995 | US5380780 Absorbable coating and blend |
01/10/1995 | US5380761 Transdermal compositions |
01/10/1995 | US5380760 Polyisobutylene adhesive |
01/10/1995 | US5380757 Method of treating vulvar dystrophy and vaginal dryness |
01/10/1995 | US5380745 Medicinal composition |
01/10/1995 | US5380711 Methods for delipidation of skin and cerumen removal |
01/10/1995 | US5380537 Single irrigating solution used in ocular therapy for the endothelium protection and cornea preservation |
01/10/1995 | US5380536 Biocompatible microcapsules |
01/10/1995 | US5380535 Chewable drug-delivery compositions and methods for preparing the same |
01/10/1995 | US5380533 Gastroresistant pharmaceutical formulations for oral administration containing bile acids |
01/10/1995 | US5380532 Pellets from solidification in super cooled fluid by forming by forcing fluids through nozzles |
01/10/1995 | US5380531 C-terminal substituted |
01/10/1995 | US5380530 Oral care composition coated gum |
01/10/1995 | US5380529 Pharmaceutical, vaginal applicable preparation and a process for its preparation |
01/10/1995 | US5380528 Silicone containing skin care compositions having improved oil control |
01/10/1995 | US5380523 High energy coprecipitate of nonoxynol oligomer, PVP and iodine having contraceptive and potent anti-HIV properties |
01/10/1995 | US5380522 Method for treatment of irritable bowel syndrome |
01/10/1995 | US5380519 Surfactant and stabilizer, ultrasonic images |
01/10/1995 | US5380473 Process for making shearform matrix |
01/10/1995 | US5380303 Method for using an antimicrobial agent for ophthalmic formulations |
01/10/1995 | CA2117399A1 Topically administrable zinc phthalocyanine compositions |
01/10/1995 | CA1333877C Perfluorocarbons for use as standards in gas partial pressure measurements |
01/07/1995 | CA2126813A1 Water-in-volatile silicone emulsion gel cosmetic |
01/05/1995 | WO1995000222A1 Drying water-containing valuable substances or mixtures thereof with superheated steam |
01/05/1995 | WO1995000199A1 Intravaginal delivery system |
01/05/1995 | WO1995000184A1 Dried hydrogel from hydrophylic-hygroscopic polymer |
01/05/1995 | WO1995000155A1 Method for the improvement of wound healing and compositions therefor |
01/05/1995 | WO1995000152A1 Pharmaceutical composition containing heparin, heparin fragments or their derivatives in combination with glycerol esters |
01/05/1995 | WO1995000151A1 Absorption enhancers for drug administration |
01/05/1995 | WO1995000144A1 Composition for ophthalmic use |
01/05/1995 | WO1995000143A1 Composition for ophthalmic use |
01/05/1995 | WO1995000136A1 Method for treating hyperkeratosis and diseases mediated by proteases |
01/05/1995 | WO1995000134A1 Liquid pharmaceutical composition for oral use containing 2-(4-isobutylphenyl)propionic acid |
01/05/1995 | WO1995000133A1 Taste-masked acetaminophen suspensions and methods of making the same |
01/05/1995 | WO1995000128A1 Compositions for inhalation |
01/05/1995 | WO1995000127A1 Therapeutic preparation for inhalation |
01/05/1995 | WO1995000126A1 Surface-modified albumin microspheres and pharmaceutical compositions containing them |
01/05/1995 | WO1995000125A1 Soft-shelled gelatin encapsulated particles |
01/05/1995 | WO1995000124A1 Enteric alkalising agent |
01/05/1995 | WO1995000123A1 Soft gelatin capsule shell compositions |
01/05/1995 | WO1995000122A1 Transdermal delivery system package |
01/05/1995 | WO1995000121A1 Compressible enzyme powder |
01/05/1995 | WO1995000120A1 Injectable microfoam containing a sclerosing agent |
01/05/1995 | WO1995000119A1 Electrostatically charged nasal application product and method |
01/05/1995 | WO1995000118A1 Intra-uterine ring for the release of an active agent, such as a hormone, and an introducer |
01/05/1995 | WO1995000088A1 Molecular transdermal transport system |
01/05/1995 | WO1994022445A3 Pharmaceutical compositions for intranasal administration of dihydroergotamine, apomorphine and morphine |